190 related articles for article (PubMed ID: 9073383)
21. Cytotoxic CD4+ T cells associated with the expression of major histocompatibility complex class II antigen of mouse myeloma cells secreting interferon-gamma are cytolytic in vitro and tumoricidal in vivo.
Xiang J; Moyana T
Cancer Gene Ther; 1998; 5(5):313-20. PubMed ID: 9824051
[TBL] [Abstract][Full Text] [Related]
22. Palmitic acid conjugation of a protein antigen enhances major histocompatibility complex class II-restricted presentation to T cells.
Robinson JH; Case MC; Brooks CG
Immunology; 1992 Aug; 76(4):593-8. PubMed ID: 1398749
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells.
Svensson M; Stockinger B; Wick MJ
J Immunol; 1997 May; 158(9):4229-36. PubMed ID: 9126984
[TBL] [Abstract][Full Text] [Related]
24. CpG-DNA aided cross-presentation of soluble antigens by dendritic cells.
Maurer T; Heit A; Hochrein H; Ampenberger F; O'Keeffe M; Bauer S; Lipford GB; Vabulas RM; Wagner H
Eur J Immunol; 2002 Aug; 32(8):2356-64. PubMed ID: 12209649
[TBL] [Abstract][Full Text] [Related]
25. Role of APC in the selection of immunodominant T cell epitopes.
Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS
J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031
[TBL] [Abstract][Full Text] [Related]
26. Class I-restricted presentation occurs without internalization or processing of exogenous antigenic peptides.
Hosken NA; Bevan MJ; Carbone FR
J Immunol; 1989 Feb; 142(4):1079-83. PubMed ID: 2492575
[TBL] [Abstract][Full Text] [Related]
27. Internalization of iscom-borne antigens and presentation under MHC class I or class II restriction.
Villacres MC; Behboudi S; Nikkila T; Lovgren-Bengtsson K; Morein B
Cell Immunol; 1998 Apr; 185(1):30-8. PubMed ID: 9636680
[TBL] [Abstract][Full Text] [Related]
28. Processing of exogenous liposome-encapsulated antigens in vivo generates class I MHC-restricted T cell responses.
Collins DS; Findlay K; Harding CV
J Immunol; 1992 Jun; 148(11):3336-41. PubMed ID: 1588035
[TBL] [Abstract][Full Text] [Related]
29. Neonatal and adult microglia cross-present exogenous antigens.
Beauvillain C; Donnou S; Jarry U; Scotet M; Gascan H; Delneste Y; Guermonprez P; Jeannin P; Couez D
Glia; 2008 Jan; 56(1):69-77. PubMed ID: 17932942
[TBL] [Abstract][Full Text] [Related]
30. A quantitative analysis of lymphokine release from activated T cells. Evidence for a novel form of T-T collaboration in vitro.
Gill RG; Lafferty KJ
J Immunol; 1989 Dec; 143(12):4009-14. PubMed ID: 2512346
[TBL] [Abstract][Full Text] [Related]
31. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
32. Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation.
Li Y; Ke Y; Gottlieb PD; Kapp JA
J Leukoc Biol; 1994 Nov; 56(5):616-24. PubMed ID: 7525819
[TBL] [Abstract][Full Text] [Related]
33. An essential role of antigen-presenting cell/T-helper type 1 cell-cell interactions in draining lymph node during complete eradication of class II-negative tumor tissue by T-helper type 1 cell therapy.
Chamoto K; Wakita D; Narita Y; Zhang Y; Noguchi D; Ohnishi H; Iguchi T; Sakai T; Ikeda H; Nishimura T
Cancer Res; 2006 Feb; 66(3):1809-17. PubMed ID: 16452242
[TBL] [Abstract][Full Text] [Related]
34. Nontoxic Shiga toxin derivatives from Escherichia coli possess adjuvant activity for the augmentation of antigen-specific immune responses via dendritic cell activation.
Ohmura M; Yamamoto M; Tomiyama-Miyaji C; Yuki Y; Takeda Y; Kiyono H
Infect Immun; 2005 Jul; 73(7):4088-97. PubMed ID: 15972497
[TBL] [Abstract][Full Text] [Related]
35. CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing.
Chu RS; Askew D; Noss EH; Tobian A; Krieg AM; Harding CV
J Immunol; 1999 Aug; 163(3):1188-94. PubMed ID: 10415013
[TBL] [Abstract][Full Text] [Related]
36. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
[TBL] [Abstract][Full Text] [Related]
37. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway.
Garg N; Nunes MP; Tarleton RL
J Immunol; 1997 Apr; 158(7):3293-302. PubMed ID: 9120286
[TBL] [Abstract][Full Text] [Related]
38. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
39. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells.
Pfeifer JD; Wick MJ; Roberts RL; Findlay K; Normark SJ; Harding CV
Nature; 1993 Jan; 361(6410):359-62. PubMed ID: 7678924
[TBL] [Abstract][Full Text] [Related]
40. Exogenous CLIP localizes into endocytic compartment of cells upon internalization: implications for antigen presentation by MHC class II molecules.
Mukherjee R; Chaturvedi P; Lee-Chan E; Singh B
Mol Immunol; 2008 Apr; 45(8):2166-76. PubMed ID: 18279957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
